NR3C1 and neoplasm: In another study on TNBC, GR modulation by using mifepristone (non-selective GR antagonist) suggested that mifepristone pre-treatment could be a useful strategy for increasing tumor cell apoptosis in chemotherapy-resistant GR positive TNBC; therefore, it can have a beneficial effect on tumor progression [180].